Category: Moderna Inc

Melanoma Vaccine Ushers in New Hope for Cancer Patients

The New York Times – Business:
Beyond melanoma, scientists are studying cancer vaccines for glioblastoma, pancreatic cancer and more.
Melanoma Vaccine Ushers in New Hope for Cancer Patients

The New York Times – Business:
Beyond melanoma, scientists are studying cancer vaccines for glioblastoma, pancreatic cancer and more.
The Winning Stock Funds This Time Weren’t Tech. They Were Energy.

The New York Times – Business:
Stock and bond fund returns for the quarter were bad nearly everywhere you looked, our columnist says. Energy stocks, lifted by the war with Iran, were an exception.
Moderna’s Shift to Cancer Company Lifts Stock Up 177%

The New York Times – Business:
The company’s fortunes cratered as demand for Covid-19 vaccines plummeted. But it was busy working on something else.
F.D.A. Approves Moderna’s mRNA Flu Vaccine

The New York Times – Business:
The agency had initially refused to even review the application but reversed course after a public outcry.
F.D.A. Reverses Decision and Agrees to Review Moderna’s Flu Vaccine

The New York Times – Business:
Moderna said it had held further discussions with regulators and announced that the agency would accept the company’s application for approval of its flu vaccine that uses mRNA technology.
U.S. Health Officials Defend Rejection of Moderna’s Flu Vaccine

The New York Times – Business:
The F.D.A.’s refusal to examine the company’s mRNA shot drew widespread criticism from doctors and was divisive within the agency.
F.D.A. Reviews Cases of Covid Vaccine Deaths

The agency plans to present accounts of deaths involving children and birth defects to an influential C.D.C. panel meeting next week.
F.D.A. Official Overruled Scientists on Wide Access to Covid Shots

The agency’s staff scientists pointed out how Covid was still unpredictable and posed a threat to toddlers, but the official decided to restrict shots only to children with risk factors.
F.D.A. Approves Covid Shots With New Restrictions

The agency’s fall recommendations underscore the goals of Health Secretary Robert F. Kennedy Jr. to limit access to the vaccines, which he has long opposed.
U.S. Cancels Contract With Moderna to Develop Bird Flu Vaccine

Health Secretary Robert F. Kennedy Jr. has repeatedly questioned the safety of mRNA technology, which is used in the company’s shot.
U.S. Cancels Contract With Moderna to Develop Bird Flu Vaccine

Health Secretary Robert F. Kennedy Jr. has repeatedly questioned the safety of mRNA technology, which is used in the company’s shot.